A study to evaluate safety and pharmacodynamic efficacy of 0382 in obese subjects with NAFLD/NASH.

Trial Identifier: D5671C00002
Sponsor: MedImmune, LLC
NCTID:: NCT04019561
Start Date: September 2019
Primary Completion Date: May 2021
Study Completion Date: May 2021
Condition: Fatty Liver Disease; Liver, Pancreas & Gallbladder - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English version
Spanish Translation

Trial Locations

Country Location
US, AZ Tucson, AZ, US, 85712
US, CA Canoga Park, CA, US, 91303
US, CA Chula Vista, CA, US, 91911
US, CA Coronado, CA, US, 92118
US, CA La Jolla, CA, US, 92093
US, CA Lincoln, CA, US, 95648
US, CA Los Angeles, CA, US, 90057
US, CA Montclair, CA, US, 91763
US, CA Oxnard, CA, US, 93030
US, CA Panorama City, CA, US, 91402
US, CA Torrance, CA, US, 90505
US, CA Westminister, CA, US, 92683
US, FL Doral, FL, US, 33166
US, FL Hialeah, FL, US, 33016
US, FL Miami, FL, US, 33125
US, FL Miami, FL, US, 33189
US, FL Palmetto Bay, FL, US, 33157
US, GA Columbus, GA, US, 31904
US, LA Marrero, LA, US, 70072
US, NC Durham, NC, US, 27705
US, NV Las Vegas, NV, US, 89104
US, NV Las Vegas, NV, US, 89109
US, OH Blue Ash, OH, US, 45242
US, PR San Juan, PR, US, 00927
US, TN Chattanooga, TN, US, 37421
US, TX Austin, TX, US, 78758
US, TX Houston, TX, US, 77002
US, TX Houston, TX, US, 77084
US, TX San Antonio, TX, US, 78229
US, TX San Antonio, TX, US, 78215
US, VA Fairfax, VA, US, 22031
US, VA Richmond, VA, US, 23219